Disclosures for "Sex-specific Differences in “Forever Chemical” Levels in Multiple Sclerosis, NMOSD, and MOGAD"
-
Dr. Montini has nothing to disclose.
-
Dr. Spurlock has received personal compensation for serving as an employee of Decode Health. Dr. Spurlock has received personal compensation for serving as an employee of New York University. Dr. Spurlock has received personal compensation for serving as an employee of IQuity Labs. Dr. Spurlock has stock in Decode Health. Dr. Spurlock has stock in IQuity Labs. The institution of Dr. Spurlock has received research support from National Institutes of Health.
-
Dr. Ryan has nothing to disclose.
-
Jessica Cooke Bailey has nothing to disclose.
-
An immediate family member of Dr. Trapl has received personal compensation for serving as an employee of Philips International. The institution of Dr. Trapl has received research support from NIH.
-
Dr. Shaginurova has nothing to disclose.
-
Dr. Wylezinski has received personal compensation for serving as an employee of Decode Health. Dr. Wylezinski has stock in Decode Health. The institution of Dr. Wylezinski has received research support from Decode Health. Dr. Wylezinski has received intellectual property interests from a discovery or technology relating to health care.
-
Ms. Sesler has received personal compensation for serving as an employee of Decode Health, Inc.. Ms. Sesler has or had stock in Decode Health, Inc.
-
Dr. Fereidan Esfahani has nothing to disclose.
-
Ms. Sagen has nothing to disclose.
-
Ms. Gardener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intersocietal Accreditation Commission. Ms. Gardener has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ellipse Analytics. Ms. Gardener has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Baum Hedlund. Ms. Gardener has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with A Green Slate Consulting.
-
Mr. McCauley has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Galatea Bio, Inc. Mr. McCauley has or had stock in Pacific Biosciences of California, Inc. . The institution of Mr. McCauley has received research support from NIH.
-
Dr. Caban-Martinez has nothing to disclose.
-
The institution of Dr. Brambilla has received research support from NIH. The institution of Dr. Brambilla has received research support from FISM. Dr. Brambilla has received intellectual property interests from a discovery or technology relating to health care. Dr. Brambilla has a non-compensated relationship as a Member of the Scientific Committee with FISM that is relevant to AAN interests or activities.
-
Dr. Amezcua has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD serono. Dr. Amezcua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Amezcua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Amezcua has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genentech. The institution of Dr. Amezcua has received research support from National MS Society. The institution of Dr. Amezcua has received research support from Genentech. The institution of Dr. Amezcua has received research support from Bristol Myers Squibb Foundation. The institution of Dr. Amezcua has received research support from NIH NINDS. The institution of Dr. Amezcua has received research support from Sanofi/Genzyme. The institution of Dr. Amezcua has received research support from Alexion.
-
The institution of Dr. Tobin has received research support from Merck. The institution of Dr. Tobin has received research support from National Institutes of Health. Dr. Tobin has received publishing royalties from a publication relating to health care. Dr. Tobin has received personal compensation in the range of $0-$499 for serving as a Paid consulting and advisory activities with Mayo Clinic Platform_Accelerate.
-
The institution of Prof. Briggs has received research support from NIH.